The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.
about
Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cellsSuppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapyEndoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cellsCisplatin in cancer therapy: molecular mechanisms of actionN-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models.MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach.Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathwayMolecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells.Preclinical Assessment of Low Doses of Cisplatin in the Management of Acute Promyelocytic LeukemiaRole of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.A Comprehensive Review on the Genetic Regulation of Cisplatin-induced NephrotoxicityFunctional classification of cellular proteome profiles support the identification of drug resistance signatures in melanoma cells.The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling.Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.Discovery of 'click' 1,2,3-triazolium salts as potential anticancer drugs.Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer.Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies.A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde.A platinum blue complex exerts its cytotoxic activity via DNA damage and induces apoptosis in cancer cells.Salvianolic acid B reverses multidrug resistance in HCT‑8/VCR human colorectal cancer cells by increasing ROS levels.Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug.Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models.Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells.The Platin-X series: activation, targeting, and delivery.Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.The relationship between platinum drug resistance and epithelial-mesenchymal transition.Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumorsDistinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells.5-Nitro-2-(3-phenylpropylamino) benzoic acid induced drug resistance to cisplatin in human erythroleukemia cell lines.Antitumour action on human glioblastoma A1235 cells through cooperation of bee venom and cisplatin.DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex.Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effectsCisplatin-Impaired Adipogenic Differentiation of Adipose Mesenchymal Stem Cells1.Deactivation of cisplatin-resistant human lung/ovary cancer cells with pyropheophorbide-α methyl ester-photodynamic therapy.Synthetic β-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
P2860
Q24299676-F1BF8E04-4CCD-4858-B403-C7C42D094F90Q24631616-10752B1A-23B9-4160-9A0A-B95A22C733D2Q28533746-5B8F06C9-558E-4F1A-B84C-8250B3B56269Q34098163-F503AEB5-18F6-47F5-B852-0C4D0D2A8930Q35071886-F88902CB-6526-43BF-8CAB-FF57B1ECEFDAQ35293359-597038BF-A8B2-47B2-8735-95F33FB9F718Q36093258-87880833-A1E1-4E77-ABFB-29115548CCB4Q36202155-245F73CD-3A52-4906-8D88-859C0CD81E3BQ36275825-660C5155-D0B7-4395-A7D7-3A64273E2C09Q36562152-0D53B00A-F08C-42AB-820A-A691752FDE1DQ36593474-9E348411-931D-490F-ADD4-DF59E496C5FEQ36895532-C652EAE6-1615-4CD4-ADE9-C21C98FCE703Q36906569-83696FCC-530F-4795-A175-3C6635C612EEQ37069163-EA9A856C-99A0-490C-9B26-41BC6153F54EQ37174716-AEDCEF6A-576D-42B6-B77D-E09FA4D19036Q37202390-3846D279-EAC4-480E-A7CC-21B63EEC0A64Q37233557-63808F28-8CB2-498B-B3C2-602B7335F91AQ37258715-DEA82344-50B8-441E-8D92-3B0EECC38D10Q37285973-240CA169-C739-40E8-9101-256C23B3A461Q37479069-D4D14655-E579-4AE3-9E86-23DEBEC5EDB1Q37729428-0AF7B3A6-7D72-4ABC-97D8-961A063E3251Q38209675-7A79745C-2711-427B-B0D9-EB163C6BCD38Q38721734-83C3E6E2-4602-4EE2-B15D-BB691C3AB525Q38725048-E51F1CCE-E6A2-4741-87D1-3EF12682DCA7Q38799693-82B30AA0-CAEA-4BF5-8C4A-6408F2310B29Q38831311-831DA796-0E64-4FBB-BAB0-919FF8F7215DQ38837587-91CE5DB0-DE48-497B-B05F-AA1493080B2AQ38853363-30057881-F7F1-43A4-9D61-E582A519AFFAQ38919253-A18C23B6-A81B-430C-B573-61FCAF06D349Q38942212-C118C426-969C-453D-B054-C0451005AAB9Q39061847-6945E93E-FDAD-4BCB-A43D-5CB2F375B006Q39108554-D88A3B08-CE4C-4489-A109-AB25311E8008Q39540757-D62A80F6-B2FE-44C7-A386-A00432235E30Q39549097-499140E4-5C53-477B-B685-3D05875AD24BQ41008643-D7A3E054-5AD6-4320-88E6-A2FAADAA59DDQ41667411-92928CEE-88F8-4FB5-9CE3-6DCDF72D569DQ42575787-ED960185-2CE9-429F-9A86-C27D7BDDE391Q44000905-6A8E1A66-1298-4B61-B8AB-C96CBB1A263CQ46277424-8A6225B6-08B2-44E6-8C41-1D92A60AA02BQ46396027-18AE9CFA-FE5F-4168-AF0D-7466D37073F5
P2860
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The relationship between cispl ...... 2 and resistance to cisplatin.
@en
The relationship between cispl ...... 2 and resistance to cisplatin.
@nl
type
label
The relationship between cispl ...... 2 and resistance to cisplatin.
@en
The relationship between cispl ...... 2 and resistance to cisplatin.
@nl
prefLabel
The relationship between cispl ...... 2 and resistance to cisplatin.
@en
The relationship between cispl ...... 2 and resistance to cisplatin.
@nl
P2093
P2860
P1476
The relationship between cispl ...... 2 and resistance to cisplatin.
@en
P2093
Anamaria Brozovic
Andreja Ambriović-Ristov
Maja Osmak
P2860
P304
P356
10.3109/10408441003601836
P407
P577
2010-04-01T00:00:00Z